REGULATORY SANDBOXES

Regulators sometimes cannot judge a new technology using rules written for established activities. A regulatory sandbox lets selected organisations run a real-world trial under an agreed plan and close regulatory supervision. The regulator clarifies how requirements apply and, where legally permitted, accepts an alternative way of meeting them or temporarily exempts the trial from a specified rule. For CDR, this could allow testing of a different monitoring approach or new permit conditions. The trial provides evidence for deciding whether and how the activity should operate more widely. Advice or a research test site alone does not provide this regulatory experiment.

Entry criteria should identify the regulatory problem, the value of testing and why ordinary advice or existing permits are insufficient. Trial plans need named participants, sites, time limits, evidence requirements and clear stop conditions. Regulators must specify which requirements can change and which remain binding, including protections they lack authority to waive. Applicants need sufficient funding to complete the trial, address harm and meet the requirements that apply afterwards. Responsibilities for compensation, site restoration and continuing monitoring should survive the trial where necessary. Data-sharing terms should protect legitimate commercial information while allowing publication of useful findings.

Supervised trials can reveal whether an unfamiliar CDR process can operate safely and whether existing requirements need adapting. Developers learn what evidence approval requires, while regulators observe practical consequences before changing rules for everyone. Testing alternative measurement approaches could improve accuracy or reduce unnecessary compliance costs. Shared findings can help other developers avoid repeating the same work. The main benefit is a better informed route from experimentation to ordinary regulation; wider deployment still requires finance, customers and any necessary permits.

Inadequate conditions or supervision can expose workers, communities or ecosystems to harm. Selective admission may favour well-connected firms, while confidential findings limit wider learning. Participants may mistake temporary permission for permanent approval, leaving projects unable to continue when the trial ends. Small trials may conceal problems that emerge at scale. Repeated extensions can create preferential treatment or postpone needed reform. Regulatory participation may be misrepresented as government endorsement of a company or its removal claims.

Evaluation should examine the regulatory question, technical performance, compliance costs, incidents and effects on affected communities. Reports need to distinguish what the technology achieved from what the regulatory flexibility changed. Findings should inform a decision to retain, amend or replace the relevant requirement. Follow-up should establish whether participants continued under ordinary rules and whether monitoring or restoration obligations remain outstanding.

Discussion should establish the rule creating difficulty and the interests it protects. Applicants explain the proposed test; regulators determine their powers and acceptable conditions. Independent experts assess evidence and safety. Affected communities can shape notification, complaints and stop procedures. Insurers clarify cover for harm, while other market participants can identify unfair entry conditions. Lawmakers need findings where legislation requires amendment.

National and regional or state regulators can supervise trials and adapt requirements within their statutory powers. Supranational institutions can establish binding arrangements that require national authorities to offer sandboxes, as under the EU Net-Zero Industry Act. Approval must involve the authority responsible for the rule being tested. A municipality needs specific regulatory authority to grant comparable flexibility; hosting a trial does not give it that power. Companies and philanthropies may participate or provide funding, but cannot waive public requirements.